Extensive genetic and epigenetic profiling of systemic metabolism to understand and prevent cardiometabolic diseases

Bidragets beskrivning

Cardiometabolic diseases, such as coronary heart disease, stroke, and diabetes, are the leading causes of death and disability in Finland and worldwide. To be able to develop novel methods for treatment and prevention, we need to understand the complex molecular pathways involved and identify biomarkers that play a causal role in the disease aetiology. Current risk evaluation strategies are focused on measuring blood cholesterol and triglyceride levels, and lipid-lowering medications function on the same lipids. Lipid metabolism, however, is a complex system, and the detailed understanding of the fine-grained molecular mechanisms is insufficient. By combining genetic analyses with extensive biomarker data covering ~1000 lipoprotein, lipid, and other metabolic measures, this project aims to deliver a detailed description of molecular pathways involved in systemic metabolism and to identify novel causal biomarkers that could serve as targets of new therapeutics.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering

Eeva Sliz Orcid -palvelun logo
246 216 €

Finansiär

Finlands Akademi

Typ av finansiering

Forskardoktorer

Övriga uppgifter

Finansieringsbeslutets nummer

338229

Vetenskapsområden

Genetik, utvecklingsbiologi, fysiologi

Forskningsområden

Perinnöllisyystiede

Identifierade teman

public health, occupational health